We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
9 hedge funds and large institutions have $585K invested in Cyclo Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
77% less capital invested
Capital invested by funds: $2.58M → $585K (-$2M)
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$280K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$152K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.82K |
| 4 |
Morgan Stanley
New York
|
+$3.44K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.62K |